about
Tumor initiation in human malignant melanoma and potential cancer therapiesTenascin-C promotes melanoma progression by maintaining the ABCB5-positive side populationOrigins of adult pigmentation: diversity in pigment stem cell lineages and implications for pattern evolutionThe pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapyInhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft modelMulti-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGelIdentification and Characterization of CXCR4-Positive Gastric Cancer Stem CellsMetabotropic glutamate receptors (mGlus) and cellular transformation.Persistence of side population cells with high drug efflux capacity in pancreatic cancer.Cancer stem cells in solid tumors: elusive or illusive?Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.Pancreatic cancer: pathobiology, treatment options, and drug delivery.Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma.A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.Current concepts of metastasis in melanoma.Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer.Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cellsNovel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasCirculating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to TreatmentExtrafollicular dermal melanocyte stem cells and melanomaVerapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.Stem cells in melanoma developmentDoes melanoma begin in a melanocyte stem cell?Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.Beyond ABC: another mechanism of drug resistance in melanoma side population.Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?Putative cancer stem cells in cutaneous malignancies.Glycoimmunomics of human cancer: current concepts and future perspectives.Divergent differentiation in malignant melanomas: a review.Melanocyte receptors: clinical implications and therapeutic relevance.Cancer stem cells and human malignant melanomaTargeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.PAX3 across the spectrum: from melanoblast to melanoma.
P2860
Q24634207-F6A884F0-BF68-46FC-BC76-5A3DDD700048Q24634572-43477659-5115-40A2-AA1D-53418411B2B4Q26825328-E1979422-00A0-418B-8DC7-7A3DBD0295E1Q27004672-03D854E1-59EF-46A4-AA9A-11FA42132A13Q27311622-0B08F465-B6E6-4C80-A0CE-1897A75A6AEEQ27343143-E4203BF7-DB40-4DC8-AEAC-F3CA7158929FQ28545737-CD807748-9C9E-4DDD-ABB4-8E8A6438B19BQ30487265-557262C7-64A6-4405-BAF2-B40738C72B17Q33317784-959E4DF4-F76B-4A08-9736-AEFA07B1A5CCQ33349066-A9983B18-DA0A-46C8-A793-D756EDB1599AQ33350614-1C13BE27-6659-4ADC-9027-0848BF726AD0Q33553311-35E53005-D723-45C8-9580-6C78604ACDCFQ33749460-5F9E6704-A67B-4FEF-901F-4D88B65F2E4BQ34044908-DA813311-AF33-47F2-8AD5-8E533AB95D2CQ34279342-4A0622D5-7A1E-4CE2-8CC3-DBB437FC68A1Q34448594-934C5D21-25FF-4986-A22D-0A44F0C1DE45Q34528954-03078806-895D-444A-AB9B-9ECDE52203E5Q34610427-190BB174-07EF-4403-8BF2-CF90981F0361Q34633885-93C590FE-B46B-45F7-A35D-EDD150D5AB6EQ35009536-B843D69E-C7D0-4E46-991F-1619E05DE2E2Q35459525-0FA1F244-C35A-41FE-9071-B2DC7D8633BAQ35535977-58191545-6E2F-4862-B332-CE88BBF97D64Q35553504-167E2830-B694-422A-9ADE-1B1A1638D22CQ35845352-772BC195-035B-4D63-AD97-B4AD1E06CB65Q35858695-40133C7E-3053-4222-B02A-2D9E99865B86Q35986737-DD5194C6-5788-419D-89F3-71F37900A028Q36017448-3B84C126-2E5B-4E8C-AFCD-552F72E00F79Q36117797-B7F94991-7998-4155-AD2B-5412D2A7D4A8Q36505859-74C8C41B-33FC-4A1B-9C54-6BD9A1D039CFQ36643787-DF6097B7-0224-46BA-B8FB-77C0F2DE60C2Q36677355-DA408EAA-984F-41BE-983A-704BE6C89D53Q36690273-58EF3065-C445-4FBD-81FE-7FF503678379Q36759571-DBA87129-F4D6-49C3-B9F1-58DEC58B484FQ36768301-F121B62A-B485-49B9-940F-7476F2A7F6FBQ36933840-0B62D8D7-A147-484B-AD7F-0510BF6729FAQ36954814-355385A3-1270-4BFD-A205-A02F5D083800Q37114128-50E0915F-F895-4D05-B8ED-0E536C8BFC69Q37144023-94AEEB8B-57D4-4DAA-A07B-9F920855533BQ37290842-160DE52B-2085-4669-835D-6968F9E33C18Q37463808-F6848EBE-E09B-44B8-AC15-E7F8527DF2CB
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Melanoma, a tumor based on a mutant stem cell?
@ast
Melanoma, a tumor based on a mutant stem cell?
@en
type
label
Melanoma, a tumor based on a mutant stem cell?
@ast
Melanoma, a tumor based on a mutant stem cell?
@en
prefLabel
Melanoma, a tumor based on a mutant stem cell?
@ast
Melanoma, a tumor based on a mutant stem cell?
@en
P2093
P356
P1476
Melanoma, a tumor based on a mutant stem cell?
@en
P2093
Carol E Vervaert
Hilliard F Seigler
James A Burch
James M Grichnik
Ryan D Schulteis
Siqing Shan
Timothy L Darrow
P2888
P304
P356
10.1038/SJ.JID.5700017
P407
P577
2006-01-01T00:00:00Z
P5875
P6179
1001002294